Completely humanized single-domain tandem chimeric antigen receptor (CAR) targeting CD5 and application thereof

Completely humanized single-domain tandem chimeric antigen receptor (CAR) targeting CD5 and application thereof

The invention discloses a fully human single-domain tandem chimeric antigen receptor (CAR) capable of being specifically bound with CD5 protein. The fully human single-domain tandem chimeric antigen receptor (CAR) comprises a CD5 binding structural domain, a transmembrane structural domain, a costim...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: WEI QIAO'E, TAN TAOCHAO, ZHOU JIANFENG, ZHAO YA, JIA XIANGYIN, DAI ZHENYU, LIU JIANWEI
Format: Patent
Sprache:chi ; eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator WEI QIAO'E
TAN TAOCHAO
ZHOU JIANFENG
ZHAO YA
JIA XIANGYIN
DAI ZHENYU
LIU JIANWEI
description The invention discloses a fully human single-domain tandem chimeric antigen receptor (CAR) capable of being specifically bound with CD5 protein. The fully human single-domain tandem chimeric antigen receptor (CAR) comprises a CD5 binding structural domain, a transmembrane structural domain, a costimulatory structural domain and an intracellular signal transduction structural domain. Also provided are engineered immune effector cells, such as T cells, comprising the chimeric antigen receptors and the use of the CARs and engineered immune effector cells for the treatment of diseases or conditions associated with the expression of CD5. 一种可以特异性结合CD5蛋白的全人源单域串联嵌合抗原受体(CAR)，其包含CD5结合结构域、跨膜结构域、共刺激结构域和胞内信号传导结构域。还提供了包含所述嵌合抗原受体的经工程化的免疫效应细胞(诸如T细胞)以及所述CAR及工程化的免疫效应细胞在用于治疗与CD5的表达相关的疾病或病症中的应用。
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN116710112A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN116710112A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN116710112A3</originalsourceid><addsrcrecordid>eNqNzL0OAUEUxfFtFIJ3uDqKTQxBvRlEpRC93Mye3b3JfGV2FDy9KTyA6jS_859WQQcXLTLsm4aXYy8ftDSK7y3qNjgWT5l9C0dmEIckhthn6eEpwSDmkGilm_u6sNQjlyfp076gljhGK4azhBIZkBC6eTXp2I5Y_HZWLS_nh77WiOGJMbKBR37qm1KHo9ootW12_5gvydxCKw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Completely humanized single-domain tandem chimeric antigen receptor (CAR) targeting CD5 and application thereof</title><source>esp@cenet</source><creator>WEI QIAO'E ; TAN TAOCHAO ; ZHOU JIANFENG ; ZHAO YA ; JIA XIANGYIN ; DAI ZHENYU ; LIU JIANWEI</creator><creatorcontrib>WEI QIAO'E ; TAN TAOCHAO ; ZHOU JIANFENG ; ZHAO YA ; JIA XIANGYIN ; DAI ZHENYU ; LIU JIANWEI</creatorcontrib><description>The invention discloses a fully human single-domain tandem chimeric antigen receptor (CAR) capable of being specifically bound with CD5 protein. The fully human single-domain tandem chimeric antigen receptor (CAR) comprises a CD5 binding structural domain, a transmembrane structural domain, a costimulatory structural domain and an intracellular signal transduction structural domain. Also provided are engineered immune effector cells, such as T cells, comprising the chimeric antigen receptors and the use of the CARs and engineered immune effector cells for the treatment of diseases or conditions associated with the expression of CD5. 一种可以特异性结合CD5蛋白的全人源单域串联嵌合抗原受体(CAR)，其包含CD5结合结构域、跨膜结构域、共刺激结构域和胞内信号传导结构域。还提供了包含所述嵌合抗原受体的经工程化的免疫效应细胞(诸如T细胞)以及所述CAR及工程化的免疫效应细胞在用于治疗与CD5的表达相关的疾病或病症中的应用。</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230905&amp;DB=EPODOC&amp;CC=CN&amp;NR=116710112A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25551,76302</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230905&amp;DB=EPODOC&amp;CC=CN&amp;NR=116710112A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WEI QIAO'E</creatorcontrib><creatorcontrib>TAN TAOCHAO</creatorcontrib><creatorcontrib>ZHOU JIANFENG</creatorcontrib><creatorcontrib>ZHAO YA</creatorcontrib><creatorcontrib>JIA XIANGYIN</creatorcontrib><creatorcontrib>DAI ZHENYU</creatorcontrib><creatorcontrib>LIU JIANWEI</creatorcontrib><title>Completely humanized single-domain tandem chimeric antigen receptor (CAR) targeting CD5 and application thereof</title><description>The invention discloses a fully human single-domain tandem chimeric antigen receptor (CAR) capable of being specifically bound with CD5 protein. The fully human single-domain tandem chimeric antigen receptor (CAR) comprises a CD5 binding structural domain, a transmembrane structural domain, a costimulatory structural domain and an intracellular signal transduction structural domain. Also provided are engineered immune effector cells, such as T cells, comprising the chimeric antigen receptors and the use of the CARs and engineered immune effector cells for the treatment of diseases or conditions associated with the expression of CD5. 一种可以特异性结合CD5蛋白的全人源单域串联嵌合抗原受体(CAR)，其包含CD5结合结构域、跨膜结构域、共刺激结构域和胞内信号传导结构域。还提供了包含所述嵌合抗原受体的经工程化的免疫效应细胞(诸如T细胞)以及所述CAR及工程化的免疫效应细胞在用于治疗与CD5的表达相关的疾病或病症中的应用。</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNzL0OAUEUxfFtFIJ3uDqKTQxBvRlEpRC93Mye3b3JfGV2FDy9KTyA6jS_859WQQcXLTLsm4aXYy8ftDSK7y3qNjgWT5l9C0dmEIckhthn6eEpwSDmkGilm_u6sNQjlyfp076gljhGK4azhBIZkBC6eTXp2I5Y_HZWLS_nh77WiOGJMbKBR37qm1KHo9ootW12_5gvydxCKw</recordid><startdate>20230905</startdate><enddate>20230905</enddate><creator>WEI QIAO'E</creator><creator>TAN TAOCHAO</creator><creator>ZHOU JIANFENG</creator><creator>ZHAO YA</creator><creator>JIA XIANGYIN</creator><creator>DAI ZHENYU</creator><creator>LIU JIANWEI</creator><scope>EVB</scope></search><sort><creationdate>20230905</creationdate><title>Completely humanized single-domain tandem chimeric antigen receptor (CAR) targeting CD5 and application thereof</title><author>WEI QIAO'E ; TAN TAOCHAO ; ZHOU JIANFENG ; ZHAO YA ; JIA XIANGYIN ; DAI ZHENYU ; LIU JIANWEI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN116710112A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>WEI QIAO'E</creatorcontrib><creatorcontrib>TAN TAOCHAO</creatorcontrib><creatorcontrib>ZHOU JIANFENG</creatorcontrib><creatorcontrib>ZHAO YA</creatorcontrib><creatorcontrib>JIA XIANGYIN</creatorcontrib><creatorcontrib>DAI ZHENYU</creatorcontrib><creatorcontrib>LIU JIANWEI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WEI QIAO'E</au><au>TAN TAOCHAO</au><au>ZHOU JIANFENG</au><au>ZHAO YA</au><au>JIA XIANGYIN</au><au>DAI ZHENYU</au><au>LIU JIANWEI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Completely humanized single-domain tandem chimeric antigen receptor (CAR) targeting CD5 and application thereof</title><date>2023-09-05</date><risdate>2023</risdate><abstract>The invention discloses a fully human single-domain tandem chimeric antigen receptor (CAR) capable of being specifically bound with CD5 protein. The fully human single-domain tandem chimeric antigen receptor (CAR) comprises a CD5 binding structural domain, a transmembrane structural domain, a costimulatory structural domain and an intracellular signal transduction structural domain. Also provided are engineered immune effector cells, such as T cells, comprising the chimeric antigen receptors and the use of the CARs and engineered immune effector cells for the treatment of diseases or conditions associated with the expression of CD5. 一种可以特异性结合CD5蛋白的全人源单域串联嵌合抗原受体(CAR)，其包含CD5结合结构域、跨膜结构域、共刺激结构域和胞内信号传导结构域。还提供了包含所述嵌合抗原受体的经工程化的免疫效应细胞(诸如T细胞)以及所述CAR及工程化的免疫效应细胞在用于治疗与CD5的表达相关的疾病或病症中的应用。</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN116710112A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Completely humanized single-domain tandem chimeric antigen receptor (CAR) targeting CD5 and application thereof
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T22%3A45%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WEI%20QIAO'E&rft.date=2023-09-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN116710112A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true